A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
Clinical trial NCT06772415 · RECRUITING
Trial details
- NCT number
- NCT06772415
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2028-12-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.